Jenny Lymary Veliz Urzua, NP

Jenny Veliz Urzua practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Jenny Veliz Urzua's NPI, 1992928972, was assigned on April 10, 2007. Jenny Veliz Urzua holds California license 16817.

Jenny Veliz Urzua's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Jenny Veliz Urzua's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Jenny Veliz Urzua is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Jenny Veliz Urzua to 1 more hospital and 2 medical groups, each named with a free account. Jenny Veliz Urzua's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Jenny Veliz Urzua practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jenny Veliz Urzua's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jenny Veliz Urzua is licensed in California.

Dmand AI lists UTI among the conditions Jenny Veliz Urzua treats.

CMS data shows 136 Medicare services from Jenny Veliz Urzua across 2 procedure codes in 2024, all of them office visits, for 128 Medicare patients. Medicare paid $15,218 for them.

CMS counts 128 Medicare patients who saw Jenny Veliz Urzua in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jenny Veliz Urzua's median patient age at 65, with 57% women.

In 2024, Jenny Veliz Urzua wrote 142 Medicare Part D claims for 66 patients. 81% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $58,929 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Jenny Veliz Urzua for performance year 2024, reported as part of a group. Jenny Veliz Urzua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jenny Veliz Urzua as offering telehealth.